SCHEMBL1393841

SCHEMBL1393841

N#CCN1CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9167025 1.00 POLB (0.60)
SCHEMBL9172023 1.00 POLB (0.60)
SCHEMBL9168067 0.97 POLB (0.58)
Hydrochloric Acid SCHEMBL2009370 0.97 SMN1; SMN2 (0.58)
Hydrochloric Acid SCHEMBL960566 0.97 SMN1; SMN2 (0.58)
SCHEMBL9172017 0.95 POLB (0.56)
SCHEMBL6537798 0.91 POLB (0.52)
Trifluoroacetic Acid SCHEMBL4504873 0.81 POLB (0.43)
SCHEMBL13779204 0.80
SCHEMBL7137154 0.80 ALDH1A1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119707838-A Synthesis method of (S) -2-piperazinylacetonitrile or salt thereof 杭州澳赛诺生物科技有限公司 2025-03-28 CN claimed
CN-116854641-A Preparation method of 2-piperazine acetonitrile derivative and 2-piperazine acetonitrile 重庆博腾制药科技股份有限公司 2023-10-10 CN claimed
CN-116855568-A Preparation of (S) -2-piperazine acetonitrile and hydrochloride thereof by enzyme resolution method 重庆博腾制药科技股份有限公司 2023-10-10 CN claimed
CN-116854642-A Preparation method of (S) -2-piperazine acetonitrile and hydrochloride thereof 重庆博腾制药科技股份有限公司 2023-10-10 CN claimed
CN-116120243-A aPKC inhibitor compound intermediate fragment, preparation method and application thereof 都创(上海)医药科技股份有限公司 2023-05-16 CN claimed
CN-101484420-A Indoles as 5-HT 6 modulators BIOVITRUM AB PUBL (SE) 2009-07-15 CN claimed
EP-4029868-B1 MCL-1 INHIBITORS GILEAD SCIENCES INC (US) 2026-05-20 EP disclosed
CN-119707838-B Synthesis method of (S) -2-piperazinylacetonitrile or salt thereof 杭州澳赛诺生物科技有限公司 2025-10-17 CN disclosed
CN-119707838-B Synthesis method of (S) -2-piperazinylacetonitrile or salt thereof 杭州澳赛诺生物科技有限公司 2025-10-17 CN disclosed
CN-119707838-A Synthesis method of (S) -2-piperazinylacetonitrile or salt thereof 杭州澳赛诺生物科技有限公司 2025-03-28 CN disclosed
CN-119707838-A Synthesis method of (S) -2-piperazinylacetonitrile or salt thereof 杭州澳赛诺生物科技有限公司 2025-03-28 CN disclosed
CN-119707838-A Synthesis method of (S) -2-piperazinylacetonitrile or salt thereof 杭州澳赛诺生物科技有限公司 2025-03-28 CN disclosed
CN-119039289-A Novel intermediate for synthesis of adaGesibirica and preparation method thereof 安庆多辉生物科技有限公司 2024-11-29 CN disclosed
EP-0832887-B1 N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug SHISEIDO CO LTD (JP) 2001-08-08 EP disclosed
WO-2001007436-A2 SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS AVENTIS PHARMACEUTICALS INC. (US) 2001-02-01 WO disclosed
US-5962456-A PEPTIC ULCERS SHISEIDO CO., LTD. (JP) 1999-10-05 US disclosed
EP-0832887-A1 N-acylpiperazine derivative, anti-ulcer drug, and antibacterial drug SHISEIDO COMPANY LIMITED (JP) 1998-04-01 EP disclosed
CN-1163612-A Preparation of immunogens and other conjugates of drugs DADE CHEMISTRY SYSTEMS INC (US) 1997-10-29 CN disclosed
CN-1134422-A Improved process for large-scale production of BMS 180048 and analogs BRISTOL MYERS SQUIBB CO (US) 1996-10-30 CN disclosed
US-3925389-A Preparation of aminoethylpiperazines TEXACO INC. 1975-12-09 US disclosed